MIRAMAR, FL, May 18, 2022 (GLOBE NEWSWIRE) -- Stemtech Corporation (“Stemtech”) (OTC-BB:STEK), an innovative nutraceutical company and a pioneer in the field of stem cell nutrition, announced today that the Company has been approved for uplisting to the OTCQB® Venture Market (the OTCQB®), which is operated by OTC Markets Group, Inc.
STEMTECH CORPORATION UPLISTS TO OTCQB
Globe Newswire - Press Release
All information and data in this article is solely for informational purposes. For more information please view the Barchart Disclosure Policy here
/Broadcom%20Inc%20HQ%20photo-by%20Sundry%20Photogrpahy%20via%20iStock.jpg)
/Super%20Micro%20Computer%20Inc%20logo%20on%20building-by%20Poetra_RH%20via%20Shutterstock.jpg)
/Intel%20Corp_%20Santa%20Clara%20campus-by%20jejim%20via%20Shutterstock.jpg)
/Apple%20Inc%20Tim%20Cook-by%20John%20Gress%20Media%20Inc%20via%20Shutterstock.jpg)